David M. Reese - 16 Mar 2026 Form 4 Insider Report for AMGEN INC (AMGN)

Role: EVP & Chief Technology Officer
Signature: /s/ David M. Reese
Issuer symbol: AMGN
Transactions as of: 16 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 18 Mar 2026, 20:38:38 UTC
Previous filing: 05 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
REESE DAVID M	EVP & Chief Technology Officer	ONE AMGEN CENTER, DRIVE, THOUSAND OAKS	/s/ David M. Reese	16 Mar 2026	0001748434

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMGN	Common Stock	Tax liability		-6,022	-13%	$366.21^*	41,787	16 Mar 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares include 744 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Content

These shares include 744 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.